Heat Biologics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTBX research report →
About the company
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases.
- CEO
- Jeffrey Wolf
- IPO
- 2013
- Employees
- 49
- HQ
- Morrisville, NC, US
Price Chart
- Market Cap
- $61.07M
- P/E
- -0.18
- P/S
- 0.00
- P/B
- -1.09
- EV/EBITDA
- -3.72
- Div Yield
- 0.00%
- Gross Margin
- 48.80%
- Op Margin
- -549.86%
- Net Margin
- -525.51%
- ROE
- 28828383.35%
- ROIC
- 342.21%
- Revenue
- $2.11M · -28.33%
- Net Income
- $-35,400,807 · -35.90%
- EPS
- $-1.41 · 13.50%
- Op Income
- $-35,419,039
- FCF YoY
- 100.00%
- 52W High
- $10.85
- 52W Low
- $1.60
- 50D MA
- $2.57
- 200D MA
- $4.11
- Beta
- 0.30
- Avg Volume
- 155.10K
Get TickerSpark's AI analysis on HTBX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 21 | Smith Edward B III | other | 32,467 |
| Dec 30, 21 | Smith Edward B III | other | 32,467 |
| Dec 13, 21 | Smith Edward B III | other | 32,467 |
| Dec 13, 21 | Ostrander William L. | other | 68,807 |
| Jan 4, 21 | Smith Edward B III | other | 65,217 |
| Jan 4, 21 | Ostrander William L. | other | 51,487 |
| Nov 12, 20 | Smith Edward B III | sell | 103,304 |
| Aug 13, 20 | Ostrander William L. | other | 15,625 |
| Aug 13, 20 | Ostrander William L. | other | 15,625 |
| Aug 13, 20 | Ostrander William L. | other | 4,440 |
Our HTBX coverage
Recent articles, reports, and earnings notes.
No research on HTBX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HTBX report →Similar companies
Peers in the same neighborhood.